SynAct Pharma AB (STO:SYNACT)
Sweden · Delayed Price · Currency is SEK 20.60
-0.10 (-0.48%)
At close: Feb 10, 2026
SynAct Pharma AB Employees
SynAct Pharma AB had 8 employees as of September 30, 2025. The number of employees increased by 3 or 60.00% compared to the same quarter last year.
Employees
8
Change
3
Growth
60.00%
Revenue / Employee
n/a
Profits / Employee
-13.28M SEK
Market Cap
1.10B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 8 | 3 | 60.00% |
| Jun 30, 2025 | 6 | 1 | 20.00% |
| Mar 31, 2025 | 6 | 1 | 20.00% |
| Dec 31, 2024 | 6 | 1 | 20.00% |
| Sep 30, 2024 | 5 | 0 | - |
| Jun 30, 2024 | 5 | 0 | - |
| Mar 31, 2024 | 5 | 0 | - |
| Dec 31, 2023 | 5 | 0 | - |
| Sep 30, 2023 | 5 | 0 | - |
| Jun 30, 2023 | 5 | 1 | 25.00% |
| Mar 31, 2023 | 5 | 0 | - |
| Dec 31, 2022 | 5 | 2 | 66.67% |
| Sep 30, 2022 | 5 | 2 | 66.67% |
| Jun 30, 2022 | 4 | 1 | 33.33% |
| Mar 31, 2022 | 5 | - | - |
| Dec 31, 2021 | 3 | - | - |
| Sep 30, 2021 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioInvent International AB | 124 |
| Oncopeptides AB | 75 |
| Diamyd Medical AB | 41 |
| Egetis Therapeutics AB | 40 |
| Genovis AB (publ.) | 36 |
| Xspray Pharma AB | 26 |
| Cantargia AB | 23 |
| Corline Biomedical AB | 13 |